Vicapsys Life Sciences (VICP) Short Interest Ratio & Short Volume

$1.51

0.00 (0.00%)

(As of 09/6/2024 ET)

Stock Analysis Chart Earnings Financials SEC Filings Short Interest

Vicapsys Life Sciences Short Interest Data

Vicapsys Life Sciences (VICP) has a short interest of 100 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 0 shares to cover all short positions.

Current Short Interest: 100 shares
Previous Short Interest: 100 shares
Change Vs. Previous Month: No Change
Dollar Volume Sold Short: $151.00
Short Interest Ratio: 0.0 Days to Cover
Last Record Date: August 15, 2024

Outstanding Shares: 32,370,000 shares
Percentage of Shares Shorted: 0.00%
Today's Trading Volume: 0 shares
Average Trading Volume: 0 shares
Today's Volume Vs. Average: NaN

Short Selling Vicapsys Life Sciences?

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Vicapsys Life Sciences and its competitors with MarketBeat's FREE newsletter.

Short Interest Chart Days to Cover Chart Short Percent of Float Chart

VICP Short Interest Over Time

VICP Days to Cover Over Time

VICP Percentage of Float Shorted Over Time

Ad Weiss Ratings

What is Nvidia’s New $1 Trillion SuperProject?

Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …

Find out details on these three critical Nvidia partners immediately.

Vicapsys Life Sciences Short Interest History

Export to Excel

Report Date	Total Shares Sold Short	Dollar Volume Sold Short	Change from Previous Report	Percentage of Float Shorted	Days to Cover	Price on Report Date
8/15/2024	100 shares	$151.00	No Change	N/A	0	$1.51
7/31/2024	100 shares	$151.00	-66.7%	N/A	1	$1.51
7/15/2024	300 shares	$1,500.00	-85.7%	N/A	0.3	$5.00
6/30/2024	2,100 shares	$14,700.00	No Change	N/A	1	$7.00
12/15/2022	100 shares	$100.00	No Change	N/A	0	$1.00
11/30/2022	100 shares	$100.00	No Change	N/A	0	$1.00
Get the Latest News and Ratings for VICP and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Vicapsys Life Sciences and its competitors with MarketBeat's FREE daily newsletter.
11/15/2022	100 shares	$100.00	No Change	N/A	0	$1.00
10/31/2022	100 shares	$100.00	No Change	N/A	0	$1.00
10/15/2022	100 shares	$100.00	No Change	N/A	0	$1.00
9/30/2022	100 shares	$100.00	No Change	N/A	1	$1.00
9/15/2022	100 shares	$100.00	No Change	N/A	0	$1.00
8/31/2022	100 shares	$100.00	-50.0%	N/A	1	$1.00
8/15/2022	200 shares	$504.00	No Change	N/A	2	$2.52
7/31/2022	200 shares	$504.00	No Change	N/A	2	$2.52
7/15/2022	200 shares	$504.00	No Change	N/A	0	$2.52
6/30/2022	200 shares	$504.00	No Change	N/A	0	$2.52
6/15/2022	200 shares	$504.00	No Change	N/A	2	$2.52
5/31/2022	200 shares	$504.00	No Change	N/A	2	$2.52
5/15/2022	200 shares	$504.00	No Change	N/A	2	$2.52
4/30/2022	200 shares	$504.00	No Change	N/A	0.7	$2.52
4/15/2022	200 shares	$520.00	No Change	N/A	2	$2.60
3/31/2022	200 shares	$520.00	No Change	N/A	0	$2.60
3/15/2022	200 shares	$520.00	No Change	N/A	0	$2.60
2/28/2022	200 shares	$520.00	No Change	N/A	0	$2.60
2/15/2022	200 shares	$520.00	No Change	N/A	2	$2.60
1/31/2022	200 shares	$1,000.00	No Change	N/A	0.7	$5.00

VICP Short Interest - Frequently Asked Questions

What is Vicapsys Life Sciences' current short interest?: Short interest is the volume of Vicapsys Life Sciences shares that have been sold short but have not yet been closed out or covered. As of August 15th, investors have sold 100 shares of VICP short. Learn More on Vicapsys Life Sciences' current short interest.
How does Vicapsys Life Sciences' short interest compare to its competitors?: Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Vicapsys Life Sciences: CytoDyn Inc. (1.02%), Helix BioPharma Corp. (0.00%), Organigram Holdings Inc. (4.60%), Skye Bioscience, Inc. (7.72%), Context Therapeutics Inc. (3.13%), Greenwich LifeSciences, Inc. (7.81%), Mersana Therapeutics, Inc. (6.94%), XBiotech Inc. (4.58%), Shattuck Labs, Inc. (12.86%), Atossa Therapeutics, Inc. (10.23%),
Which stocks are the most shorted right now?: As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.23 billion), Aptiv PLC ($2.50 billion), Royal Caribbean Cruises Ltd. ($2.48 billion), Paychex, Inc. ($2.25 billion), Moderna, Inc. ($2.17 billion), Cencora, Inc. ($2.12 billion), Tractor Supply ($1.93 billion), Onsemi ($1.82 billion), International Paper ($1.81 billion), and Rivian Automotive, Inc. ($1.72 billion). View all of the most shorted stocks.

What does it mean to sell short Vicapsys Life Sciences stock?: Short selling VICP is an investing strategy that aims to generate trading profit from Vicapsys Life Sciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.
How does a short squeeze work against Vicapsys Life Sciences?: A short squeeze for Vicapsys Life Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VICP, which in turn drives the price of the stock up even further.
How often is Vicapsys Life Sciences' short interest reported?: Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VICP, twice per month. The most recent reporting period available is August, 15 2024.